GlassScriptPhysician profile
Alexis Anvekar
NPI 1306952577
$1,202.03
in general payments reported to CMS, 2019-2025
19 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $191 · 2021: $264 · 2022: $83.79 · 2023: $106 · 2024: $260 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.47 | 2019-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $171.72 | 2020-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $165.15 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $100.44 | 2023-2025 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $80.26 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $53.44 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $50.11 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.00 | 2020 | |
| Ironshore Pharmaceuticals INC. | $36.73 | 2019 | |
| Nabriva Therapeutics, Plc | $28.77 | 2020 | |
| Eisai INC. | $23.78 | 2021 | |
| Novo Nordisk INC | $23.37 | 2025 | Wegovy |
| Astellas Pharma US INC | $22.43 | 2019 | |
| Alk-Abello, INC | $18.64 | 2024 | Ragwitek, Odactra, Grastek |
| Pfizer INC. | $18.18 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.37 | 2020 | |
| Radius Health, INC. | $16.27 | 2020 | |
| Sanofi Pasteur INC. | $15.76 | 2019 | |
| Adlon Therapeutics L.P. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Anvekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.